Home
Sites

Channels

Choose a channel

Check out the different Progress in Mind content channels.

Select country

Depression & Schizophrenia

Treating comorbidity of depression and anxiety and addressing side effects of some medications

At ECNP 2021, Professor Roger McIntyre chatted with us about anxiety in people with major depressive disorder (MDD) and how it can impact both MDD symptoms and recovery. Treating anxiety can help alleviate MDD and lead to better overall health outcomes. Also discussed was how people with schizophrenia or MDD may be fully open to taking a treatment; however, if they then experience sedating or activating side effects, it can be frustrating for both the patients and physicians and can lead to treatment discontinuation and then potential symptom worsening.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
Not located in Brazil?
Go to a different regional HUB
Continue to Progress in MindContinue to Progress in Mind BrazilContinue to Progress in Mind SpainContinue to Progress in Mind ItalyContinue to Progress in Mind
You are leaving Progress in Mind
Continue to
Cancel
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Accept
Decline
Congress
Register for access to Progress in Mind in your country
Cancel
New member registration